Royalty Pharma plc - Class A RPRX Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$67.57 up $0.01, 0.01% at close Nov 5
Last close · Previous close $67.56
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- 1.37%Last 12 months
Price chart
$67.57up $0.01, 0.01%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$67.56Nov 4
- Volume4.90MNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume3.32MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $37.31 to $69.77; now $67.57
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
RPRX beat the S&P 500 in all 6 periods.
| Period | RPRX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | RPRX: up 19.3% S&P 500: down 5.4% | RPRX beat the S&P 500 by 24.7 percentage points Beat |
| 3M | RPRX: up 17.5% S&P 500: down 4.5% | RPRX beat the S&P 500 by 22.0 percentage points Beat |
| YTD | RPRX: up 77.3% S&P 500: up 8.3% | RPRX beat the S&P 500 by 69.0 percentage points Beat |
| 1Y | RPRX: up 70.4% S&P 500: up 9.3% | RPRX beat the S&P 500 by 61.1 percentage points Beat |
| Long term | ||
| 3Y | RPRX: up 160.9% S&P 500: up 74.8% +37.7% vs +20.5% a year | RPRX beat the S&P 500 by 86.1 percentage points Beat |
| 5Y | RPRX: up 92.1% S&P 500: up 67.3% +13.9% vs +10.8% a year | RPRX beat the S&P 500 by 24.8 percentage points Beat |
$10,000 invested in RPRX 5 years ago (Nov 5, 2021) would be worth about $19,210 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,730.
RPRX beat the S&P 500 in all 6 periods.
| Period | RPRX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | RPRX: up 19.3% S&P 500: down 5.4% | RPRX beat the S&P 500 by 24.7 percentage points Beat |
| 3M | RPRX: up 17.0% S&P 500: down 4.8% | RPRX beat the S&P 500 by 21.8 percentage points Beat |
| YTD | RPRX: up 74.9% S&P 500: up 7.5% | RPRX beat the S&P 500 by 67.4 percentage points Beat |
| 1Y | RPRX: up 67.2% S&P 500: up 8.2% | RPRX beat the S&P 500 by 59.0 percentage points Beat |
| Long term | ||
| 3Y | RPRX: up 141.8% S&P 500: up 68.6% +34.2% vs +19.0% a year | RPRX beat the S&P 500 by 73.2 percentage points Beat |
| 5Y | RPRX: up 71.0% S&P 500: up 56.4% +11.3% vs +9.4% a year | RPRX beat the S&P 500 by 14.6 percentage points Beat |
$10,000 invested in RPRX 5 years ago (Nov 5, 2021) would be worth about $17,098 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,645.
All-time high
$67.57
Closing high on .
Split-adjusted daily closes since Jun 16, 2020.
Stock splits
RPRX hasn’t split since its price history begins in 2020.
Valuation
Financials
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $0.000 |
| 2019 | $0.000 |
| 2020 | $0.30 |
| 2021 | $0.68 |
| 2022 | $0.76 |
| 2023 | $0.80 |
| 2024 | $0.84 |
| 2025 | $0.88 |
| 2026 (to date) | $0.71 |
Dividend details
- $0.93Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield1.37%Last 12 months
- $0.24Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- 4 yearsThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
About Royalty Pharma plc - Class A
Royal Pharma Plc
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
RPRX news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
RPRX stock FAQ
What is RPRX stock’s price today?
Royalty Pharma (RPRX) traded at $67.57 at the close on , up $0.01 (0.01%) from the previous close of $67.56. Over the past 52 weeks it has traded between $37.31 and $69.77.
If you invested $1,000 in RPRX 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in RPRX on would be worth about $1,921 at the close on , a total return of +92.1%. The same $1,000 would be worth $1,704 if invested one year ago. Past performance doesn’t predict future returns.
Does RPRX pay a dividend?
Yes. Royalty Pharma pays a quarterly dividend. The most recent was $0.24 per share, with an ex-dividend date of . Over the last twelve months it paid $0.93 per share, a 1.37% yield at the close, and the full-year dividend has risen 4 years in a row (how dividend yield works).
Based on the last 12 months’ payments ($0.93 per share), and if the next 12 months match the last 12, 100 shares would receive about $93 over 12 months, and $1,000 over 12 months would take about 1,082 shares, roughly $73,111 at the close. Dividends can change.
What is RPRX’s 52-week high and low?
Over the past 52 weeks RPRX has traded as low as $37.31 and as high as $69.77. At $67.57 at the close on , it is 3.2% below that high and 81.1% above the low.
What is RPRX’s all-time high?
RPRX’s highest closing price was $67.57 on , adjusted for stock splits.
Has RPRX stock ever split?
No. RPRX hasn’t split since its price history begins in 2020.
How has RPRX stock performed?
Including dividends and measured to the close on , RPRX has returned +77.3% so far this year and +70.4% over the past year, and +92.1% over five years (+13.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What exchange does RPRX trade on?
Royalty Pharma trades on the Nasdaq under the ticker symbol RPRX. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.